IFNL3 and chronic hepatitis C virus infection: Several recent studies suggested that the expressions of ISGs in liver [19] and plasma [20] are associated with genetic variation in IL28B and the outcome of interferon therapy for chronic hepatitis C. The expression of hepatic ISGs is strongly associated with treatment response and genetic variation of IL28B [19].